04386nam 2200673Ia 450 991096808240332120240516122658.097816080513281608051323(CKB)2670000000067026(EBL)864213(OCoLC)819594352(SSID)ssj0000494865(PQKBManifestationID)11326006(PQKBTitleCode)TC0000494865(PQKBWorkID)10453020(PQKB)11295234(MiAaPQ)EBC864213(Au-PeEL)EBL864213(CaPaEBR)ebr10447992(DE-B1597)732022(DE-B1597)9781608051328(EXLCZ)99267000000006702619990506d2011 uy 0engur|n|---|||||txtccrAnastin and malignant gliomas /editor, Thomas C. Chen ; co-editor, Marc Chamberlain1st ed.[S.l.] Bentham e Books[2011]1 online resource (219 p.)Controversies in neuro-oncologyDescription based upon print version of record.9781608055197 1608055191 Includes bibliographical references and indexes.01 Cover Page.pdf; 02 Title Page; 03 eBooks End User License Agreement-Website; 04 table of contents; 05 Foreword; 06 PREFACE-Avastin; 07 Contributors; 08 Part 1 BASIC SCIENCE AND RATIONALE; 09 Ch-1; 10 Part 2; 11 Ch-2 Desjardins-Avastin-recurrent-chen; 12 Ch-3 kreisl-Avastin_and_Mailgnant_Gliomas_-_Is_there_a_role[1]-chen; 13 Ch-4 GutinRT-_bev_review_FI_PG_9-22[1]-chen; 14 Ch-5 norden_controversies_6-19-09[1]-chen; 15 Part 3; 16 Ch-6 Reardon_chapter_8[1].29; 17 Ch-7 Mehta-radiationControversies_in_Neuro-Avastin-final[1]-chen18 Ch-8 Gilbert-Bevacizumab_and_Malignant_Glioma_final_version_9-14-09[1]-Gilbert-chen19 Part 4; 20 Ch-9 Schiff-Avastin toxicityFinal-Bevacizumab_Toxicity_in_Glioblastoma_with_DS_edits_090109-for_review_11[1]-chen corrected; 21 Ch-10 Rogers Chapter_-_Avastin_and_AC_-_Chamberlain_11-2-09__3_[2]-Chen; 22 Part 5; 23 Ch-11 Raizer- AvastinFinal__2_[1]-chen; 24 Part 6; 25 Ch-12 POPE_GBM_Avastin_Imaging[1]-chen; 26 Ch-13 Butowski-radiographic responses 2-chen; 27 Ch-14 Imaging Responses of Bevacizuma; 28 Ch-15 HENSON091509cleanref[1]-chen; 29 Part 7; 30 Ch-16 Aghi-_Avastin_v2[1]-Chen31 Ch-17 Vogelbaum-Surgical Implications-Avastin_Final[1]-chen32 Part 8; 33 Ch-18 chamberlain-BevNovelApplications_8_6_09[1]-chen; 34 Ch-19 Levin-Radiation_necrosis-082509-Final[1]-chen; 35 Ch-20 chamberlain-salvage-chen; 36 Part 9; 37 Ch-21 StuppBev_rec_glioma__final[1]-chen; 38 Ch-22 van den Bent-Avastin in Europe-chen; 39 Ch-23 Avastin_Weller_2009-6-30[1]-chen; 40 Ch-24 Wick European pers-chen; 41 Part 10; 42 Ch-25 Sunitinib_ebook_chapter___B_Neyns[1]-chen; 43 Ch-26 nabors-cilengitide-chen; 44 Ch-27 SorafenibChapter_FINAL[2]-chen; 45 Ch-28 Wen-VEGF-trap_8-14-09_FINAL[1]-chen46 Ch-29 Batchelor-Gerstner-Dietrich-Cediranib-09-12-09[1]-chen47 Part 11 Conclusion; 48 Ch-30 Gu Development_of_Bevacizumab[1][1]-chen; 49 Author Index -Avastin; 50 Index-final-chenNeuro-oncology is an embryonic field of cancer research with a number of clinical trials in progress. However, the prognosis on neuro-oncologic patients has remained poor. Moreover, several small scale phase I/II trials performed have proved to be inconclusive because of the limited number of patients involved. As a result, many controversies exist in neuro-oncology drug development for which a forum does not exist. This ebook presents a detailed account on the use of avastin in treating cancer patients. A discussion on clinical experiences and the controversial debate among researchers of avaControversies in Neuro-Oncology, 1GliomasBevacizumabGliomas.Bevacizumab.616.8Chen Thomas C, authttp://id.loc.gov/vocabulary/relators/aut1800194Chen Thomas C1800194Chamberlain Marc C1800195MiAaPQMiAaPQMiAaPQBOOK9910968082403321Anastin and malignant gliomas4344839UNINA02698nam 2200649Ia 450 991101971700332120200520144314.0978661234300197804706874510470687452978111920617011192061709781282343009128234300997804707424950470742496(CKB)1000000000578521(EBL)406526(OCoLC)317599594(SSID)ssj0000271171(PQKBManifestationID)12113258(PQKBTitleCode)TC0000271171(PQKBWorkID)10294846(PQKB)11056178(MiAaPQ)EBC406526(Perlego)1008915(EXLCZ)99100000000057852120080809d2008 uy 0engur|n|---|||||txtccrWhere in the world is my team making a success of your virtual global workplace /Terence BrakeWest Sussex, England John Wiley & Sons Incc20081 online resource (239 p.)Description based upon print version of record.9780470714294 0470714298 Where in the World is My Team?; CONTENTS; ACKNOWLEDGEMENTS; CAST OF CHARACTERS; WELCOME MAT; LET THE GAMES BEGIN; COOPERATION; CONVERGENCE; COORDINATION; CAPABILITY; COMMUNICATION; CULTURAL INTELLIGENCE; SHOWTIME: ALL TOGETHER NOW!; BRIEFING REPORT: GLOBAL VIRTUAL TEAM ESSENTIALS; USEFUL TERMSAs the economy becomes increasingly global, businesses need employees who can work in teams that cross borders and transcend physical spaces. In Where in the World Is My Team, fictional character Will Williams shares entertaining anecdotes and practical advice to accustom readers to the challenges of a global, virtual workplace. This easy-to-follow guide, ideal for managers and those interested in succeeding in a global economy, introduces new technologies but focuses especially on the six Key Performance Zones for global team collaboration with briefing report summaries to emphasize key pointMultinational work teamsVirtual work teamsTeams in the workplaceMultinational work teams.Virtual work teams.Teams in the workplace.341.242658.4022Brake Terence477136MiAaPQMiAaPQMiAaPQBOOK9911019717003321Where in the world is my team4421955UNINA